Gether L., Overgaard L.K., Egeberg A., Thyssen J.P. Incidence and prevalence of rosacea: a systematic review and meta-analysis // Br. J. Dermatol. 2018. Vol. 179. N. 2. P. 282–289. DOI: https://doi.org/10.1111/bjd.16481. Epub 2018 May 31. PMID: 29478264.
Gold L.S., Papp K., Lynde C. et al. Treatment of rosacea with concomitant use of topical ivermectin 1% cream and brimonidine 0.33% gel: a randomized, vehicle-controlled study // J. Drugs Dermatol. 2017. Vol. 16. N. 9. P. 909–916. PMID: 28915286.
González H.P., Santas M.D., Domper L.F. et al. Ex vivo dermoscopy in demodicosis // J. Am. Acad. Dermatol. 2023. Vol. 88. N. 3. P. e127–e128. DOI: https://doi.org/10.1016/j.jaad.2021.07.031. Epub 2021 Jul 27. PMID: 34329644.
Gorin I., Gaitz J.P., Chevrier C. et al. Maladie du Morbihan: Essais therapeutiques. Deuxième présentation. Paris, 1991. Abstract “Journées Dermatologiques de Paris”. P. 111.
Gül U., Gönül M., Kiliç A. et al. A case of granulomatous rosacea successfully treated with pimecrolimus cream // J. Dermatolog. Treat. 2008. Vol. 19. N. 5. P. 313–315. DOI: https://doi.org/10.1080/09546630802032595. PMID: 18608739.
Gupta V., Mridha A.R., Sharma V.K. Sebaceous hyperplasia and sebaceous adenomas presenting as leonine facies and improving with oral isotretinoin // Clin. Exp. Dermatol. 2016. Vol. 41. N. 8. P. 923–924. DOI: https://doi.org/10.1111/ced.12918. Epub 2016 Oct 19. PMID: 27859604.
Helm K.F., Menz J., Gibson L.E., Dicken C.H. A clinical and histopathologic study of granulomatous rosacea // J. Am. Acad. Dermatol. 1991. Vol. 25. N. 6. Pt 1. P. 1038–1043. DOI: https://doi.org/10.1016/0190-9622(91)70304-k.
Hilbring C., Augustin M., Kirsten N., Mohr N. Epidemiology of rosacea in a population-based study of 161,269 German employees // Int. J. Dermatol. 2022. Vol. 61. N. 5. P. 570–576. DOI: https://doi.org/10.1111/ijd.15989. Epub 2021 Dec 12. PMID: 34897653.
Holmes A.D., Waite K.A., Chen M.C. et al. Dermatological adverse events associated with topical brimonidine gel 0.33% in subjects with erythema of rosacea: a retrospective review of clinical studies // J. Clin. Aesthet. Dermatol. 2015. Vol. 8. N. 8. P. 29–35. PMID: 26345379; PMCID: PMC4557848.
Hu S.W., Robinson M., Meehan S.A., Cohen D.E. Morbihan disease // Dermatol. Online J. 2012. Vol. 18. N. 12. P. 27. PMID: 23286817.
Husein-ElAhmed H., Steinhoff M. Efficacy of topical ivermectin and impact on quality of life in patients with papulopustular rosacea: a systematic review and meta-analysis // Dermatol. Ther. 2020. Vol. 33. N. 1. Article ID e13203. DOI: https://doi.org/10.1111/dth.13203. Epub 2020 Jan 2. PMID: 31863543.
Jang Y.H., Sim J.H., Kang H.Y. et al. Immunohistochemical expression of matrix metalloproteinases in the granulomatous rosacea compared with the non-granulomatous rosacea // J. Eur. Acad. Dermatol. Venereol. 2011. Vol. 25. N. 5. P. 544–548. DOI: https://doi.org/10.1111/j.1468-3083.2010.03825.x. PMID: 20698913.
Jang Y.J., Hong E.H., Park E.J. et al. Immunohistochemical analysis of differences of toll-like receptor 2, mast cells, and neurofilaments between granulomatous rosacea and non-granulomatous rosacea // Indian J. Dermatol. 2021. Vol. 66. N. 4. P. 343–346. DOI: https://doi.org/10.4103/ijd.IJD_18_20. PMID: 34759390; PMCID: PMC8530054.
Jansen T, Plewig G. Rosacea: classification and treatment // J. R. Soc. Med. 1997. Vol. 90. N. 3. P. 144–150. DOI: https://doi.org/10.1177/014107689709000308.
Jansen T., Plewig G., Kligman A.M. Diagnosis and treatment of rosacea fulminans // Dermatology. 1994. Vol. 188. N. 4. P. 251–254. DOI: https://doi.org/10.1159/000247160. PMID: 8193395.
Jarrett R., Gonsalves R., Anstey A.V. Differing obstetric outcomes of rosacea fulminans in pregnancy: report of three cases with review of pathogenesis and management // Clin. Exp. Dermatol. 2010. Vol. 35. N. 8. P. 888–891. DOI: https://doi.org/10.1111/j.1365-2230.2010.03846.x. PMID: 20456381.
Jiang Y., Huang Y., Ma G. et al. Granulomatous rosacea in Chinese patients: clinical-histopathological analysis and pathogenesis exploration // J. Dermatol. 2023. Vol. 50. N. 7. P. 856–886. DOI: https://doi.org/10.1111/1346-8138.16767. Epub 2023 Apr 5. PMID: 37020415.
Johnson A.W., Johnson S.M. The role of topical brimonidine tartrate gel as a novel therapeutic option for persistent facial erythema associated with rosacea // Dermatol. Ther. (Heidelb.). 2015. Vol. 5. N. 3. P. 171–181. DOI: https://doi.org/10.1007/s13555-015-0078-1. Epub 2015 Jun 26. PMID: 26112098; PMCID: PMC4580655.
Johnson-Arbor K. Ivermectin: a mini-review // Clin. Toxicol. (Phila.). 2022. Vol. 60. N. 5. P. 571–575. DOI: https://doi.org/10.1080/15563650.2022.2043338. Epub 2022 Feb 28. PMID: 35225114.
Jungfer B., Jansen T., Przybilla B., Plewig G. Solid persistent facial edema of acne: successful treatment with isotretinoin and ketotifen // Dermatology. 1993. Vol. 187. P. 34–37. URL: https://eyewiki.org/File:Morbihan_Pathology.jpg.
Kang C.N., Shah M., Tan J. Rosacea: an update in diagnosis, classification and management // Skin Therapy Lett. 2021. Vol. 26. N. 4. P. 1–8. PMID: 34347259.
Khokhar O., Khachemoune A. A case of granulomatous rosacea: sorting granulomatous rosacea from other granulomatous diseases that affect the face // Dermatol. Online J. 2004. Vol. 10. N. 1. P. 6.
Kim S.J., Lee Y., Seo Y.J. et al. Comparative efficacy of radiofrequency and pulsed dye laser in the treatment of rosacea // Dermatol. Surg. 2017. Vol. 43. N. 2. P. 204–209. DOI: https://doi.org/10.1097/DSS.0000000000000968. PMID: 27893539.